174 related articles for article (PubMed ID: 28470790)
1. High-risk cutaneous squamous cell carcinoma in a Japanese allogeneic bone marrow transplant recipient on long-term voriconazole.
Ng W; Takahashi A; Muto Y; Yamazaki N
J Dermatol; 2017 Oct; 44(10):1152-1155. PubMed ID: 28470790
[TBL] [Abstract][Full Text] [Related]
2. Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patients.
Wojenski DJ; Bartoo GT; Merten JA; Dierkhising RA; Barajas MR; El-Azhary RA; Wilson JW; Plevak MF; Hogan WJ; Litzow MR; Patnaik MM; Wolf RC; Hashmi SK
Transpl Infect Dis; 2015 Apr; 17(2):250-8. PubMed ID: 25661996
[TBL] [Abstract][Full Text] [Related]
3. Effect of voriconazole on risk of nonmelanoma skin cancer after hematopoietic cell transplantation.
Kuklinski LF; Li S; Karagas MR; Weng WK; Kwong BY
J Am Acad Dermatol; 2017 Oct; 77(4):706-712. PubMed ID: 28780363
[TBL] [Abstract][Full Text] [Related]
4. Increased incidence of cutaneous squamous cell carcinoma in lung transplant recipients taking long-term voriconazole.
Feist A; Lee R; Osborne S; Lane J; Yung G
J Heart Lung Transplant; 2012 Nov; 31(11):1177-81. PubMed ID: 22841559
[TBL] [Abstract][Full Text] [Related]
5. Voriconazole exposure and risk of cutaneous squamous cell carcinoma among lung or hematopoietic cell transplant patients: A systematic review and meta-analysis.
Tang H; Shi W; Song Y; Han J
J Am Acad Dermatol; 2019 Feb; 80(2):500-507.e10. PubMed ID: 30130598
[TBL] [Abstract][Full Text] [Related]
6. Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.
D'Arcy ME; Pfeiffer RM; Rivera DR; Hess GP; Cahoon EK; Arron ST; Brownell I; Cowen EW; Israni AK; Triplette MA; Yanik EL; Engels EA
JAMA Dermatol; 2020 Jul; 156(7):772-779. PubMed ID: 32401271
[TBL] [Abstract][Full Text] [Related]
7. Secondary Skin Cancer in a Case with Long-term Voriconazole after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.
Kawano N; Nakamura S; Mochida K; Yoshida S; Kuriyama T; Nakaike T; Shimokawa T; Tochigi T; Yamashita K; Mashiba K; Kikuchi I; Takarabe A; Moriguchi S; Mori Y; Takenaka K; Shimoda K; Ochiai H; Amano M
Intern Med; 2022 Sep; 61(18):2771-2774. PubMed ID: 35022348
[TBL] [Abstract][Full Text] [Related]
8. A pediatric case of squamous cell cancer in situ in the setting of sclerodermatous graft-versus-host disease and voriconazole treatment.
Li AW; Lalor LE; Bellodi Schmidt F; Luu M
Pediatr Dermatol; 2018 May; 35(3):e165-e169. PubMed ID: 29570823
[TBL] [Abstract][Full Text] [Related]
9. Incidence and Risk Factors for De Novo Cutaneous Squamous Cell Carcinoma in a Contemporary Cohort of Long-Term Hematopoietic Cell Transplantation Survivors.
Berano Teh J; Abdulla F; Peng K; Atencio L; Echevarria M; Iukuridze A; Geller AC; Wong FL; Forman SJ; Nakamura R; Modi B; Armenian SH
J Invest Dermatol; 2021 Aug; 141(8):2073-2076.e5. PubMed ID: 33609555
[No Abstract] [Full Text] [Related]
10. Risk Factors for Keratinocyte Carcinoma in Recipients of Allogeneic Hematopoietic Cell Transplants.
Scott JF; Brough KR; Grigoryan KV; Muzic JG; Kim GY; Conic RRZ; Hill ST; Brewer JD; Baum CL; Litzow MR; Hogan WJ; Patnaik MS; Hashmi SK; Lazarus HM; Bordeaux JS; Thompson CL; Gerstenblith MR; Lehman JS
JAMA Dermatol; 2020 Jun; 156(6):631-639. PubMed ID: 32267479
[TBL] [Abstract][Full Text] [Related]
11. Characterizing the cutaneous late effects of allogeneic hematopoietic stem cell transplantation: A systematic review.
Bourkas AN; Sibbald C; Chan AW; Schechter T; Ali M; Pullattayil AK; Levy R
Pediatr Transplant; 2024 Feb; 28(1):e14618. PubMed ID: 37786978
[TBL] [Abstract][Full Text] [Related]
12. Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole.
Cowen EW; Nguyen JC; Miller DD; McShane D; Arron ST; Prose NS; Turner ML; Fox LP
J Am Acad Dermatol; 2010 Jan; 62(1):31-37. PubMed ID: 19896749
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous phaeohyphomycosis in a hematopoietic stem cell transplant patient caused by Alternaria rosae: First case report.
Liu AW; Bateman AC; Greenbaum A; Garvin K; Clarridge J; Grim J
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28295973
[TBL] [Abstract][Full Text] [Related]
14. Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients.
Mansh M; Binstock M; Williams K; Hafeez F; Kim J; Glidden D; Boettger R; Hays S; Kukreja J; Golden J; Asgari MM; Chin-Hong P; Singer JP; Arron ST
Am J Transplant; 2016 Jan; 16(1):262-70. PubMed ID: 26372838
[TBL] [Abstract][Full Text] [Related]
15. Rapid and sustained response to immune checkpoint inhibition in cutaneous squamous cell carcinoma after allogenic hematopoietic cell transplant for sézary syndrome.
Khaddour K; Musiek A; Cornelius LA; Dehdashti F; Westervelt P; Fields R; Ansstas G
J Immunother Cancer; 2019 Dec; 7(1):338. PubMed ID: 31801591
[TBL] [Abstract][Full Text] [Related]
16. The incidence of cutaneous squamous cell carcinoma in patients receiving voriconazole therapy for chronic pulmonary aspergillosis.
Kosmidis C; Mackenzie A; Harris C; Hashad R; Lynch F; Denning DW
Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2233-2237. PubMed ID: 32820348
[TBL] [Abstract][Full Text] [Related]
17. Risk-adjusted relationship between voriconazole utilization and non-melanoma skin cancer among lung and heart/lung transplant patients.
McLaughlin JM; Equils O; Somerville KT; Aram JA; Schlamm HT; Welch VL; Mardekian J; Barbers RG
Transpl Infect Dis; 2013 Aug; 15(4):329-43. PubMed ID: 23489832
[TBL] [Abstract][Full Text] [Related]
18. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
[TBL] [Abstract][Full Text] [Related]
19. Persistent poor long-term prognosis of allogeneic hematopoietic stem cell transplant recipients surviving invasive aspergillosis.
Salmeron G; Porcher R; Bergeron A; Robin M; Peffault de Latour R; Ferry C; Rocha V; Petropoulou A; Xhaard A; Lacroix C; Sulahian A; Socié G; Ribaud P
Haematologica; 2012 Sep; 97(9):1357-63. PubMed ID: 22371177
[TBL] [Abstract][Full Text] [Related]
20. High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients.
Singer JP; Boker A; Metchnikoff C; Binstock M; Boettger R; Golden JA; Glidden DV; Arron ST
J Heart Lung Transplant; 2012 Jul; 31(7):694-9. PubMed ID: 22484291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
